Skip to main content
Publish date:

5 Top Stock Gainers for Tuesday: Alcoa, Chubb, Dish Network

Alcoa, Chubb, Dish Network, HCA Healthcare and Immunome are five top stock gainers for Tuesday.

Stocks finished higher Tuesday with Wall Street clawing back losses from Monday's selloff as investors turned their attention to a slew of earnings reports.

Here are some of the top gainers for Tuesday:

1. Alcoa | Increase 11%

Shares of Alcoa  (AA) - Get Alcoa Corporation Report rose after aluminum titan was upgraded to conviction buy from buy at Goldman Sachs. Analyst Emily Chieng said Alcoa has "significant leverage to a positive commodity price outlook," where every 10% increase in aluminum prices corresponds to a 20% increase in Ebitda, according to the Fly.

2. Chubb | Increase 4.3%

Chubb  (CB) - Get Chubb Limited Report shares advanced after the insurance company's board approved a new one-time incremental share repurchase program of up to $5 billion through June 30, 2022. The company said its current buyback authorization of $2.5 billion has $65 million remaining, which would be used prior to the latest program.

TheStreet Recommends

3. Dish Network | Increase 4.7%

Dish Network  (DISH) - Get DISH Network Corporation Class A Report climbed after the satellite television service provider said it had signed a deal valued at a minimum $5 billion to make AT&T  (T) - Get AT&T Inc. Report the primary network-services partner for its wireless customers. Under the terms of the 10-year deal, AT&T will provide voice, data, messaging services to customers of Dish-owned mobile virtual network operators Boost Mobile, Ting and Republic Wireless.

4. HCA Healthcare | Increase 14%

HCA Healthcare  (HCA) - Get HCA Healthcare Inc Report jumped after the hospital operator beat Wall Street's second-quarter earnings expectations. Net income came to $1.45 billion, or $4.36 a share. The FactSet consensus called for earnings of $3.16 a share. Revenue totaled $14.43 billion, up from $11.07 a year earlier and beating FactSet's consensus of $13.6 billion.

5. Immunome | Increase 9%

Immunome  (IMNM) - Get Immunome, Inc. Report shares rose after the biopharmaceutical company said its three-antibody cocktail, IMM-BCP-01, demonstrated "potent neutralizing activity" against the COVID-19 delta variant in preclinical pseudovirus testing. The company said in February that it had isolated antibodies that could blunt several COVID types.